Zobrazeno 1 - 10
of 437
pro vyhledávání: '"Stegeman, CA"'
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde, 156. Bohn Stafleu van Loghum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::42ce94f69f467aa1ea95dc2e98cd5a66
https://pure.eur.nl/en/publications/7c79eac1-5ce8-4c12-a6a0-6f1456d53d38
https://pure.eur.nl/en/publications/7c79eac1-5ce8-4c12-a6a0-6f1456d53d38
Autor:
van Geenen, EJM, de Boer, NKH, Stassen, P, Linskens, RK, Bruno, Marco, Mulder, CJJ, Stegeman, CA, van Bodegraven, AA
Publikováno v:
Alimentary Pharmacology & Therapeutics, 31(12), 1322-1329. Wiley-Blackwell Publishing Ltd
P>Background Several reports suggest an increased rate of adverse reactions to azathioprine in patients with Crohn's disease. Aim To compare the incidence of thiopurine-induced acute pancreatitis in patients with inflammatory bowel disease (IBD) with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::18cafe47eece692e916da1c4452752d9
https://pure.eur.nl/en/publications/7ac74028-a078-4817-80b1-0049970b51f2
https://pure.eur.nl/en/publications/7ac74028-a078-4817-80b1-0049970b51f2
Autor:
Stegeman, CA
Publikováno v:
Journal of Rheumatology, 32(11), 2075-2077. J RHEUMATOL PUBL CO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::06ad4cc782fa3afbec371ec11b9eeb53
https://research.rug.nl/en/publications/50303f3d-55d2-4062-a85e-b843f77e2d14
https://research.rug.nl/en/publications/50303f3d-55d2-4062-a85e-b843f77e2d14
Autor:
Tervaert, JWC, Stegeman, CA
Publikováno v:
LANCET, 364(9442), 1313-1314. ELSEVIER SCIENCE INC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::3f1950bc31e6c1479a97aa5e514c9ce6
https://research.rug.nl/en/publications/e5c61aac-7aad-4e1d-b5a4-096f86044b79
https://research.rug.nl/en/publications/e5c61aac-7aad-4e1d-b5a4-096f86044b79
Publikováno v:
ARTHRITIS AND RHEUMATISM, 51(2), 269-273. John Wiley and Sons Inc.
Objective. To analyze disease-free survival in patients with antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis (AAV) treated with cyclophosphamide only or switched to azathioprine after 3 months of full remission while tak
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::9fabc740f5c5eeec0380263b78504409
https://research.rug.nl/en/publications/ac3e7b9c-3b51-4bc4-b4ec-588be99b26c3
https://research.rug.nl/en/publications/ac3e7b9c-3b51-4bc4-b4ec-588be99b26c3
Publikováno v:
Kidney International, 63(2), 670-677. ELSEVIER SCIENCE INC
Background. Severe renal disease is a feature of anti-neutrophil cytoplasmic antibodies (ANCA)-associated small-vessel vasculitis. We evaluated patient and renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with ren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::348a157b575e61e54c6cb2eaa8597a67
https://research.rug.nl/en/publications/802ac3bb-046b-470b-a7df-160d3c373dc2
https://research.rug.nl/en/publications/802ac3bb-046b-470b-a7df-160d3c373dc2
Autor:
Van der Leij, J, Van der Berg, A, Albrecht, EWJA, Blokzijl, T, Roozendaal, R, Gouw, ASH, Stegeman, CA, Van Goor, H, Chang, NS, Poppema, S
Publikováno v:
Blood, 100(11), 397B-398B. AMER SOC HEMATOLOGY
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::37840b6f002224fe9cd44cce25b886f4
https://research.rug.nl/en/publications/5e7c1b3b-a824-4c78-b73f-a085d8c14d10
https://research.rug.nl/en/publications/5e7c1b3b-a824-4c78-b73f-a085d8c14d10
Publikováno v:
Journal of the American Society of Nephrology, 13(9):UNSP 1046-6673/1309-2232. AMER SOC NEPHROLOGY
Wegener granulomatosis (WG) is strongly associated with the presence of antineutrophil cytoplasm autoantibodies (ANCA) with specificity for proteinase 3 (PR3). Relapses of WG are frequently preceded by a rise of autoantibody titer and PR3-ANCA are ab
Publikováno v:
Osteoporosis International, 13(1), 74-82. SPRINGER LONDON LTD
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a relapsing-remitting disease, which is treated with corticosteroids (CS) in combination with cyclophosphamide. One of the major side-effects of this treatment is osteoporosis, whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::853c2178ae69b20c8f1399ec7a70cc37
https://research.rug.nl/en/publications/3b448d79-c645-40bd-9ae7-889306030a78
https://research.rug.nl/en/publications/3b448d79-c645-40bd-9ae7-889306030a78
Autor:
Stegeman, CA, Kallenberg, CGM
Publikováno v:
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 23(3), 231-251
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::920a715b47c17085fc5a4e5e1c429196
https://research.rug.nl/en/publications/f2fe16f8-3a25-4f4b-bb2c-dcd32865de97
https://research.rug.nl/en/publications/f2fe16f8-3a25-4f4b-bb2c-dcd32865de97